Study of cord blood levels of erythropoietin, bilirubin and reticulocyte count as early predictors of neonatal hyperbilirubinemia

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Observational

Source

TCTR

Registry ID

TCTR20201031001

Enrollment

Unknown

Registered

2020-10-31

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbilirubinemia Neonate&#44

Interventions

Diagnostic,Diagnostic

cases or patient group,control group

group 1(45 neonates) and those who developed pathological significant UH & required treatment (cases or patient group),group 2(45 neonates) and those who did not develop pathological significant UH &r

Eligibility

Sex/Gender

All

Age

28 Days to 28 Days

Inclusion criteria

Inclusion criteria: neonates suffering from neonatal hyperbilirubinemia

Exclusion criteria

Exclusion criteria: neonatal infections

Design outcomes

Primary

Measure	Time frame
neonatal hyperbilirubinemia at birth Cord blood EPO level was measured by enzyme-linked immunosorbent assay (ELISA)	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Egypt

Contacts

Public Contactmohamed elfarargy

Tanta University Hospital

farargy2009@hotmail.com+201005171750

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Study of cord blood levels of erythropoietin&#44; bilirubin and reticulocyte count as early predictors of neonatal hyperbilirubinemia